Adjunctive therapy with an oral H 2 S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction.

Autor: Doiron JE; Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, Louisiana, USA., Xia H; Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, Louisiana, USA.; Cardiovascular Center of Excellence, LSU Health Sciences Center, New Orleans, Louisiana, USA., Yu X; Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Nevins AR; Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., LaPenna KB; Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, Louisiana, USA., Sharp TE 3rd; Molecular Pharmacology and Physiology, University of South Florida, Tampa, Florida, USA., Goodchild TT; Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Allerton TD; Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA., Elgazzaz M; Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, Louisiana, USA.; Cardiovascular Center of Excellence, LSU Health Sciences Center, New Orleans, Louisiana, USA., Lazartigues E; Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, Louisiana, USA.; Cardiovascular Center of Excellence, LSU Health Sciences Center, New Orleans, Louisiana, USA., Shah SJ; Feinberg School of Medicine, Northwestern University Medicine, Chicago, Illinois, USA., Li Z; Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Lefer DJ; Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2024 Nov; Vol. 181 (21), pp. 4294-4310. Date of Electronic Publication: 2024 Jul 09.

Efficacy of different oral H 1 antihistamine treatments on allergic rhinitis: a systematic review and network meta-analysis of randomized controlled trials.

Autor: Hong D; Shenzhen Traditional Chinese Medicine Hospital, Department of Otorhinolaryngology, People's Republic of China, Shenzhen, China., Weng J; Shenzhen Traditional Chinese Medicine Hospital, Department of Otorhinolaryngology, People's Republic of China, Shenzhen, China., Ye M; Shenzhen Traditional Chinese Medicine Hospital, Department of Otorhinolaryngology, People's Republic of China, Shenzhen, China., Liu Y; Shenzhen Traditional Chinese Medicine Hospital, Department of Otorhinolaryngology, People's Republic of China, Shenzhen, China. Electronic address: yxl_sztcm@163.com.

Publikováno v: Brazilian journal of otorhinolaryngology [Braz J Otorhinolaryngol] 2023 Jul-Aug; Vol. 89 (4), pp. 101272. Date of Electronic Publication: 2023 Apr 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Midede H. pylori Eradikasyon Oranları Oral H. pylorinin Dişeti (Periodontal) Tedavisi ile Eliminasyonu ile Artırılabilir mi? Literatür Taraması. (Turkish)

Autor: ÖZTÜRK, Ayla

Publikováno v: Current Research in Dental Sciences; Jul2023, Vol. 33 Issue 3, p174-178, 5p

Intranasal antihistamine is superior to oral H 1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis.

Autor: Du K; Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Key Laboratory of Otolaryngology Head and Neck Surgery, Capital Medical University, Ministry of Education, Beijing, People's Republic of China., Qing H; Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China., Zheng M; Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Key Laboratory of Otolaryngology Head and Neck Surgery, Capital Medical University, Ministry of Education, Beijing, People's Republic of China., Wang X; Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Key Laboratory of Otolaryngology Head and Neck Surgery, Capital Medical University, Ministry of Education, Beijing, People's Republic of China; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, People's Republic of China. Electronic address: entwxd@vip.sina.com., Zhang L; Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Key Laboratory of Otolaryngology Head and Neck Surgery, Capital Medical University, Ministry of Education, Beijing, People's Republic of China; Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, People's Republic of China; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, People's Republic of China. Electronic address: dr.luozhang@gmail.com.

Publikováno v: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2020 Nov; Vol. 125 (5), pp. 589-596.e3. Date of Electronic Publication: 2020 Jul 07.